TEV-316
N/A
Report date: 2024/12/18 16:55:06
Base Information
Drug NameTEV-316
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMabxience SaTeva Pharmaceutical Industries Ltd
China Registration ClassN/A
Develop Information
Active CompaniesMabxience SaTeva Pharmaceutical Industries Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A